Stanford Translational Cardio-Oncology Program
About the program
The Stanford Translational Cardio-Oncology Program is a rich, collaborative, and multi-disciplinary program which employs clinical data, bio-banked samples, animal and cellular models to study the cardiotoxic mechanisms of oncologic drugs and discover cures. Utilizing close collaborations across disciplines such as oncology and immunology, it aims to build pipelines for biobanking, clinical data gathering, clinical protocol optimization, and basic science discovery efforts to provide treatments for cardio-oncologic diseases and improve clinical care of the cardio-oncology patient population.
The goal of the Stanford Translational Cardio-Oncology Program is to facilitate bench-to-bedside research in the field of cardio-oncology and cardio-immunology in order to bring diagnostic tools and therapeutic solutions to patients.